Unknown

Dataset Information

0

Optimal Allocation of the Limited COVID-19 Vaccine Supply in South Korea.


ABSTRACT: Initial supply of the coronavirus disease (COVID-19) vaccine may be limited, necessitating its effective use. Herein, an age-structured model of COVID-19 spread in South Korea is parameterized to understand the epidemiological characteristics of COVID-19. The model determines optimal vaccine allocation for minimizing infections, deaths, and years of life lost while accounting for population factors, such as country-specific age distribution and contact structure, and various levels of vaccine efficacy. A transmission-blocking vaccine should be prioritized in adults aged 20-49 years and those older than 50 years to minimize the cumulative incidence and mortality, respectively. A strategy to minimize years of life lost involves the vaccination of adults aged 40-69 years, reflecting the relatively high case-fatality rates and years of life lost in this age group. An incidence-minimizing vaccination strategy is highly sensitive to vaccine efficacy, and vaccines with lower efficacy should be administered to teenagers and adults aged 50-59 years. Consideration of age-specific contact rates and vaccine efficacy is critical to optimize vaccine allocation. New recommendations for COVID-19 vaccines under consideration by the Korean Centers for Disease Control and Prevention are mainly based on a mortality-minimizing allocation strategy.

SUBMITTER: Shim E 

PROVIDER: S-EPMC7914460 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Optimal Allocation of the Limited COVID-19 Vaccine Supply in South Korea.

Shim Eunha E  

Journal of clinical medicine 20210204 4


Initial supply of the coronavirus disease (COVID-19) vaccine may be limited, necessitating its effective use. Herein, an age-structured model of COVID-19 spread in South Korea is parameterized to understand the epidemiological characteristics of COVID-19. The model determines optimal vaccine allocation for minimizing infections, deaths, and years of life lost while accounting for population factors, such as country-specific age distribution and contact structure, and various levels of vaccine ef  ...[more]

Similar Datasets

| S-EPMC8268243 | biostudies-literature
| S-EPMC4614506 | biostudies-literature
| S-EPMC8313510 | biostudies-literature
| S-EPMC8632406 | biostudies-literature
| S-EPMC8209775 | biostudies-literature
| S-EPMC8699630 | biostudies-literature
| S-EPMC8053003 | biostudies-literature
| S-EPMC8076816 | biostudies-literature
| S-EPMC8203851 | biostudies-literature
| S-EPMC7576111 | biostudies-literature